Lv3
290 积分 2025-04-09 加入
ERJ Viewpoint: vascular targeted therapies for fibrotic lung disease – Start of a new era?
1个月前
已关闭
ERJ Viewpoint: vascular targeted therapies for fibrotic lung disease – Start of a new era?
1个月前
已关闭
Clinical-imaging characteristics and management of anti-JO-1 and non-JO-1 anti-synthetase syndrome–associated interstitial lung disease
4个月前
已完结
Both Inducible and Constitutive Activator Protein-1-Like Transcription Factors Are Used for Transcriptional Activation of the Galanin Gene by Different First and Second Messenger Pathways
7个月前
已完结
One-Pot Chemo-, Regio-, and Stereoselective Double-Differential Glycosidation Mediated by Lanthanide Triflates
7个月前
已完结
Physiology, Signaling, and Pharmacology of Galanin Peptides and Receptors: Three Decades of Emerging Diversity
8个月前
已完结
The galanin peptide family in inflammation
9个月前
已完结
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
9个月前
已完结
FGF21 Signaling Exerts Anti-Fibrotic Properties During Pulmonary Fibrosis
9个月前
已完结
Collagen Post-Translational Modifications Are Altered in IPF Including within ECM Receptor Binding Motifs
10个月前
已完结
皖公网安备34019202002308
